FRI0326 Efficacy and Safety of Tabalumab, an Anti-B Cell Activating Factor Monoclonal Antibody, in Patients with Rheumatoid Arthritis Who HAD an Inadequate Response to Methotrexate Therapy: Results from A Phase 3 Multicenter, Randomized, Double-Blind Study

Abstract

BackgroundTabalumab is a monoclonal antibody that neutralizes membrane-bound and soluble B cell activating factor (BAFF).ObjectivesEvaluate efficacy and safety of tabalumab, in RA pts who had an inadequate response to methotrexate...